Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwei Wei

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Emerging Microbes & Infections|June 22, 2026
Deep mutational scanning reveals the antibody escape and infectivity landscape of SARS-CoV-2 Omicron JN.1 and XEC receptor-binding domainsChengwei Shao, Lisa Yang, Chuyao Xiao, et al.
Infectious Diseases and Therapy|May 8, 2026
Post-Marketing Active Surveillance of Adverse Events Following Quadrivalent Subunit Influenza Vaccine in Healthy Participants Aged ≥ 3 Years in ChinaMingwei Wei, Yu Pan, Kangning Wang, et al.
Frontiers in Public Health|August 20, 2025
Respiratory pathogens in infants and young children with acute respiratory illness: a prospective cohort study, China, 2023-2024Yuqing Li, Mingwei Wei, Lunbiao Cui, et al.
Emerging Microbes & Infections|November 14, 2022
Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohortLiguo Zhu, Naiying Mao, Changhua Yi, et al.
Expert Review of Vaccines|November 11, 2024
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialPengfei Jin, Qiao Liu, Wenli Chen, et al.
Clinical and Translational Medicine|September 14, 2022
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsDeyan Luo, Hongxing Pan, Peng He, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Emerging Microbes & Infections|June 22, 2026
Deep mutational scanning reveals the antibody escape and infectivity landscape of SARS-CoV-2 Omicron JN.1 and XEC receptor-binding domainsChengwei Shao, Lisa Yang, Chuyao Xiao, et al.
Infectious Diseases and Therapy|May 8, 2026
Post-Marketing Active Surveillance of Adverse Events Following Quadrivalent Subunit Influenza Vaccine in Healthy Participants Aged ≥ 3 Years in ChinaMingwei Wei, Yu Pan, Kangning Wang, et al.
Frontiers in Public Health|August 20, 2025
Respiratory pathogens in infants and young children with acute respiratory illness: a prospective cohort study, China, 2023-2024Yuqing Li, Mingwei Wei, Lunbiao Cui, et al.
Emerging Microbes & Infections|November 14, 2022
Impact of vaccination on kinetics of neutralizing antibodies against SARS-CoV-2 by serum live neutralization test based on a prospective cohortLiguo Zhu, Naiying Mao, Changhua Yi, et al.
Expert Review of Vaccines|November 11, 2024
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trialPengfei Jin, Qiao Liu, Wenli Chen, et al.
Clinical and Translational Medicine|September 14, 2022
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsDeyan Luo, Hongxing Pan, Peng He, et al.
Pageof 4